Variant report
Variant | nsv966327 |
---|---|
Chromosome Location | chr4:148346351-148351227 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:10)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:10 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | E2F4 | chr4:148349630-148349964 | MCF10A-Er-Src | breast: | n/a | n/a |
2 | FOS | chr4:148349638-148350093 | MCF10A-Er-Src | breast: | n/a | n/a |
3 | FOS | chr4:148349630-148350111 | MCF10A-Er-Src | breast: | n/a | n/a |
4 | FOS | chr4:148349642-148350066 | MCF10A-Er-Src | breast: | n/a | n/a |
5 | FOS | chr4:148349649-148350098 | MCF10A-Er-Src | breast: | n/a | n/a |
6 | MYC | chr4:148349995-148350004 | MCF10A-Er-Src | breast: | n/a | n/a |
7 | MYC | chr4:148349706-148349879 | MCF10A-Er-Src | breast: | n/a | n/a |
8 | POLR2A | chr4:148350499-148350528 | MCF10A-Er-Src | breast: | n/a | n/a |
9 | POLR2A | chr4:148349632-148349641 | GM12878 | blood: | n/a | n/a |
10 | POLR2A | chr4:148347653-148347713 | ProgFib | skin: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000241281 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2059907 | chr4:148347665-148347666 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs573720508 | chr4:148347701-148347702 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs2059908 | chr4:148347706-148347707 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs13133409 | chr4:148347861-148347862 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs386680583 | chr4:148347870-148347871 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs13115345 | chr4:148347872-148347873 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs199955351 | chr4:148347876-148347877 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs536304721 | chr4:148347953-148347954 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs370378168 | chr4:148347955-148347956 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs13138606 | chr4:148347971-148347972 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs13140151 | chr4:148347993-148347994 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs540331648 | chr4:148348005-148348006 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs540952497 | chr4:148348007-148348008 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs117822013 | chr4:148348072-148348073 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs528910489 | chr4:148348095-148348096 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs4362803 | chr4:148348109-148348110 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs563223778 | chr4:148348110-148348111 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs368723157 | chr4:148348133-148348134 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs75962490 | chr4:148348194-148348195 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs371533431 | chr4:148348210-148348211 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs577602144 | chr4:148348234-148348235 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs2884270 | chr4:148348261-148348262 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs2357780 | chr4:148348301-148348302 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs539372909 | chr4:148348398-148348399 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs527858599 | chr4:148348404-148348405 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs547503107 | chr4:148348410-148348411 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs367810484 | chr4:148348432-148348433 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs567404741 | chr4:148348465-148348466 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs372027447 | chr4:148348507-148348508 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs71594211 | chr4:148348556-148348557 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs536274842 | chr4:148348577-148348578 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs3064541 | chr4:148348578-148348579 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs75383678 | chr4:148348579-148348580 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs2884271 | chr4:148348584-148348585 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs569174022 | chr4:148348614-148348615 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs537756925 | chr4:148348646-148348647 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs34429650 | chr4:148348680-148348681 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs577781175 | chr4:148348706-148348707 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs34273504 | chr4:148348727-148348728 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs10019644 | chr4:148348749-148348750 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs553938481 | chr4:148348760-148348761 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs573779705 | chr4:148348767-148348768 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs561481630 | chr4:148348852-148348853 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs191114366 | chr4:148348856-148348857 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs11732075 | chr4:148348868-148348869 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs531290726 | chr4:148348895-148348896 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs545400047 | chr4:148348896-148348897 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs34780385 | chr4:148348905-148348906 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs398108111 | chr4:148348913-148348914 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs111694851 | chr4:148348944-148348945 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 16272173 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21633010 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:148347800-148348400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
2 | chr4:148348000-148348400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
3 | chr4:148348000-148348400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
4 | chr4:148348200-148349400 | Enhancers | NHEK | skin |
5 | chr4:148348400-148349600 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
6 | chr4:148349600-148349800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
7 | chr4:148350400-148350600 | Active TSS | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
8 | chr4:148350600-148354400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
9 | chr4:148351000-148351600 | Enhancers | Ovary | ovary |